Teladoc Health, Inc. which can be found using ticker (TDOC) now have 22 analysts in total covering the stock. The consensus rating is pointing to ‘hold’. The target price High/Low ranges between 40 and 25 suggesting an average Analsyt target price of $30.08. Now with the previous closing price of $24.65 this is indicating there is a potential upside of 22.0%. The 50 day moving average now sits at $25.52 and the 200 moving average now moves to $27.71. The total market capitalization for the company now stands at 3.96B. The stock price is currently at: 24.17 USD
The potential market cap would be $4,827,355,938 based on the market consensus.
The company is not paying dividends at this time.
Other points of data to note are a P/E ratio of -, revenue per share of 15.25 and a -1.83% return on assets.
Teladoc Health, Inc. provides virtual healthcare services. The Company operates through two segments: Teladoc Health Integrated Care (Integrated Care) and BetterHelp. Its Integrated Care segment includes a range of global virtual medical services, including general medical, expert medical services, specialty medical, chronic condition management, mental health, and enabling technologies and enterprise telehealth solutions for hospitals and health systems. It offers its integrated care services primarily on a business-to-business (B2B) basis. Its BetterHelp segment primarily consists of its direct-to-consumer (D2C) mental health platform. The online counseling and therapy services are provided via its network of over 30,000 licensed clinicians leveraging its platform for Web, mobile app, phone, and text-based interactions. Its consumer brands include Teladoc, Livongo by Teladoc Health, and BetterHelp, which delivers access to advice and resolution for a range of healthcare needs.
